v3.26.3
STOCKHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY
On June 24, 2026, the Company effected a reverse stock split of the Company’s common stock, par value $0.01 per share, at a ratio of 1-for-3. All comparable periods presented have been retrospectively revised to reflect this change.

Share Repurchase Program
In November 2025, the Company's Board of Directors approved a new share repurchase authorization of up to $2 billion of common stock (the "$2B Authorization").

In the fourth quarter of 2025, DuPont entered into an accelerated share repurchase ("ASR") agreement with one counterparty for the repurchase of approximately $500 million of common stock ("Q4 2025 ASR Transaction"). DuPont paid an aggregate of $500 million to the counterparty, and the counterparty was required to deliver a variable number of shares to the Company. DuPont received initial deliveries of 3.4 million shares of DuPont common stock, which were retired immediately and recorded as an increase of $400 million to "Accumulated Deficit" in the Consolidated Statements of Equity.

In January 2026, the Q4 2025 ASR Transaction was completed. The settlement resulted in delivery of approximately 700,000 shares of additional DuPont common stock, which were retired immediately and recorded as an increase of $90 million to "Accumulated Deficit" in the Consolidated Statements of Equity. In total, the Company repurchased 4.1 million shares at an average price of $122.66 per share under the Q4 2025 ASR Transaction.

In May 2026, DuPont entered into an ASR agreement with one counterparty for the repurchase of approximately $275 million of common stock ("Q2 2026 ASR Transaction"). DuPont paid an aggregate of $275 million to the counterparty, and the counterparty was required to deliver a variable number of shares to the Company. Within the same month, the Q2 2026 ASR Transaction was completed. The Q2 2026 ASR Transaction resulted in delivery of approximately 1.8 million shares of DuPont common stock, at an average price of $148.91 per share, which were retired immediately and recorded as an increase of $270 million to "Accumulated Deficit" in the Consolidated Statements of Equity.

In August 2026, DuPont entered into an ASR agreement with one counterparty for the repurchase of approximately $250 million of common stock ("Q3 2026 ASR Transaction"). DuPont paid an aggregate of $250 million to the counterparty, and the counterparty was required to deliver a variable number of shares to the Company. Within the same month, the Q3 2026 ASR Transaction was completed. The Q3 2026 ASR Transaction resulted in delivery of approximately 1.8 million shares of DuPont common stock, at an average price of $139.17 per share, which were retired immediately and recorded as an increase of $252 million to "Accumulated Deficit" in the Consolidated Statements of Equity.

In September 2026, DuPont entered into a $100 million open market repurchase agreement ("Q3 2026 OMR") under the $2B Authorization and repurchased approximately 700,000 shares of DuPont common stock, at an average price of $128.80 per share, which were retired immediately and recorded as an increase of $86 million to "Accumulated Deficit" in the Consolidated Statements of Equity.

Subsequent to the quarter-end, in October 2026, the Q3 2026 OMR was completed. The settlement resulted in delivery of approximately 100,000 additional DuPont common Stock for $14 million at an average price of $129.45 per share, which were retired immediately. In total, the Company repurchased approximately 800,000 shares at an average price of $128.89 per share under the Q3 2026 OMR.
Accumulated Other Comprehensive Loss
The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the nine months ended September 30, 2026 and 2025:
Accumulated Other Comprehensive LossCumulative Translation AdjPension and OPEBDerivative InstrumentsTotal
In millions
2025
Balance at January 1, 2025$(1,493)$(115)$108 $(1,500)
Other comprehensive income (loss) before reclassifications
757 (23)(74)660 
Amounts reclassified from accumulated other comprehensive loss— 5 — 5 
Net other comprehensive income (loss)
$757 $(18)$(74)$665 
Balance at September 30, 2025
$(736)$(133)$34 $(835)
2026
Balance at January 1, 2026$(437)$(125)$37 $(525)
Other comprehensive (loss) income before reclassifications(136)3 18 (115)
Amounts reclassified from accumulated other comprehensive loss — 1 — 1 
Aramids Divestiture reclassification adjustment43 (6)— 37 
Net other comprehensive (loss) income$(93)$(2)$18 $(77)
Balance at September 30, 2026
$(530)$(127)$55 $(602)
The tax effects on the net activity related to each component of other comprehensive loss were not significant for the three and nine months ended September 30, 2026 and 2025.